
Athersys ATHX
Athersys ROCE Ratio | ATHX
Annual ROCE Ratio Athersys
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 322.88 | -531.85 | -213.09 | -157.79 | -54.15 | -141.57 | -123.32 | -84.28 | -120.75 | -82.02 | -69.19 | -166.41 | -127.83 | -82.37 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 322.88 | -531.85 | -116.55 |
Quarterly ROCE Ratio Athersys
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 180.34 | 365.62 | -6958.34 | -6981.99 | -7114.4 | -7270.28 | -7549.65 | -329.14 | -266.61 | -261.87 | -217.74 | -231.9 | -204.92 | -200.09 | -201.3 | -154.44 | -138.32 | -112.43 | -70.66 | -56.21 | -85.95 | -94.25 | -130.61 | -130.92 | -113.16 | -121.87 | -37.47 | -15.57 | -58.79 | -52.92 | -52.34 | -112.37 | -139.48 | -119.85 | -111.86 | -75.61 | -124.37 | -149.77 | -178.8 | -153.89 | -371.83 | -403.29 | -402.62 | -350.0 | -379.86 | -188.91 | -148.12 | -96.29 | -29.86 | -27.0 | -39.42 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 365.62 | -7549.65 | -828.85 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Global Blood Therapeutics
GBT
|
-146.47 | - | - | $ 4.62 B | ||
|
Inozyme Pharma
INZY
|
-179.9 | - | - | $ 207 M | ||
|
NanoString Technologies
NSTG
|
-332.18 | - | -37.43 % | $ 5.1 M | ||
|
Humanigen
HGEN
|
146.06 | - | -81.12 % | $ 4.28 M | ||
|
CNS Pharmaceuticals
CNSP
|
-353.49 | $ 3.56 | -9.07 % | $ 1.58 M | ||
|
Sorrento Therapeutics
SRNE
|
2710.64 | - | -29.58 % | $ 126 M | ||
|
Surface Oncology
SURF
|
-66.24 | - | - | $ 59.7 M | ||
|
Sierra Oncology
SRRA
|
-98.03 | - | -0.05 % | $ 1.34 B | ||
|
Vaccinex
VCNX
|
753.01 | - | -61.37 % | $ 654 K | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
63.22 | - | -19.68 % | $ 18.4 M | ||
|
Jounce Therapeutics
JNCE
|
-28.53 | - | - | $ 98.4 M | ||
|
Cocrystal Pharma
COCP
|
-120.22 | $ 0.93 | -4.11 % | $ 10.5 M | ||
|
Fortress Biotech
FBIO
|
-56.86 | $ 1.89 | 6.78 % | $ 52.7 M | ||
|
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | ||
|
Longeveron
LGVN
|
-377.18 | $ 1.65 | -9.34 % | $ 29 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | ||
|
Immunic
IMUX
|
1572.16 | $ 7.0 | -5.28 % | $ 1.09 B | ||
|
Immunovant
IMVT
|
-70.24 | $ 31.74 | -2.4 % | $ 5.79 B | ||
|
Mersana Therapeutics
MRSN
|
-36.18 | - | - | $ 3.56 B | ||
|
Akari Therapeutics, Plc
AKTX
|
-48.61 | $ 6.83 | 1.71 % | $ 460 B | ||
|
MediWound Ltd.
MDWD
|
-38.77 | $ 13.59 | 0.33 % | $ 370 M | ||
|
CymaBay Therapeutics
CBAY
|
-25.56 | - | - | $ 3.45 B | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-187.83 | - | - | $ 384 M | ||
|
Keros Therapeutics
KROS
|
21.27 | $ 11.04 | -3.07 % | $ 411 M | ||
|
Kazia Therapeutics Limited
KZIA
|
-45.76 | $ 4.9 | -8.75 % | $ 75.9 M | ||
|
Allakos
ALLK
|
-155.07 | - | - | $ 28.6 M | ||
|
Timber Pharmaceuticals
TMBR
|
-367.47 | - | - | $ 717 K | ||
|
G1 Therapeutics
GTHX
|
-111.7 | - | - | $ 370 M | ||
|
Amryt Pharma plc
AMYT
|
-5.86 | - | - | $ 621 M | ||
|
BioVie
BIVI
|
-216.67 | $ 0.79 | -13.64 % | $ 5.72 M | ||
|
Kinnate Biopharma
KNTE
|
-76.05 | - | - | $ 123 M | ||
|
Mustang Bio
MBIO
|
-25.13 | $ 0.35 | -4.3 % | $ 1.72 M | ||
|
Cerevel Therapeutics Holdings
CERE
|
-38.85 | - | - | $ 7.29 B | ||
|
NexImmune
NEXI
|
-939.5 | - | 70.13 % | $ 4.12 M | ||
|
Theravance Biopharma
TBPH
|
6.74 | $ 17.03 | 0.03 % | $ 857 M | ||
|
Nuvation Bio
NUVB
|
-41.57 | $ 3.79 | -0.52 % | $ 1.29 B | ||
|
IMV
IMV
|
-79.29 | - | - | $ 13.1 M | ||
|
Chimerix
CMRX
|
-79.36 | - | - | $ 756 M | ||
|
LogicBio Therapeutics
LOGC
|
-126.88 | - | - | $ 229 M | ||
|
AbbVie
ABBV
|
-461.01 | $ 286.15 | 0.94 % | $ 506 B | ||
|
89bio
ETNB
|
-95.97 | - | - | $ 1.55 B | ||
|
Harpoon Therapeutics
HARP
|
-1265.51 | - | - | $ 763 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
14.33 | $ 143.74 | -2.76 % | $ 18.8 B | ||
|
Amgen
AMGN
|
104.87 | $ 435.4 | -0.21 % | $ 234 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
349.59 | $ 0.29 | -11.35 % | $ 3.57 B | ||
|
Seagen
SGEN
|
-21.46 | - | - | $ 42.2 B | ||
|
Baudax Bio
BXRX
|
156.69 | - | 0.59 % | $ 63 K | ||
|
ChemoCentryx
CCXI
|
-45.41 | - | - | $ 3.74 B | ||
|
Avid Bioservices
CDMO
|
-30.68 | - | - | $ 789 M | ||
|
Zosano Pharma Corporation
ZSAN
|
-95.62 | - | 7.23 % | $ 2.72 M |